Skip to main content Accessibility help
×
Home

Technological Development of Lipid-Based Microcylinders: Biocompatibility and Controlled Release

  • Barry J. Spargo (a1), Geoffrey E. Stilwell (a2), Richard O. Cliff (a2), Rod L. Monroy (a3), Florence M. Rollwagen (a3) and Alan S. Rudolph (a1)...

Abstract

We have developed a lipid-based microcylinder for the controlled release of biological response modifiers. Lipid microcylinders are composed of 1,2-ditricosa-10,12-diynoyl-sn-glycerol-3-phosphocholine which form hollow cylinders 50–250 μm in length with a diameter approximately 0.5–1.0 μm. Amphiphilic molecules such as ganglioside (5–6 mol%) can be incorporated into the bilayers of the microcylinder, modulating surface characteristics of the structure.

In this study, we have examined the biocompatibility of lipid microcylinders and lipid microcylinders containing 6 mol% ganglioside. The interaction of microcylinders with peripheral blood monocytes and three cell lines: U937, a histocytic monocyte; K562, an erythroblast, and; a Jurkat derivative, a lymphoblast was assessed. Toxicity, as measured by proliferative status of the cell lines, was not evident at lipid concentrations up to 100 μg/ml lipid. Peripheral blood monocytes were observed to closely associate, but not engulf lipid microcylinders. However, when ganglioside was present in the lipid microcylinders this interaction was markedly decreased.

We have begun to measure the release rates of growth factors such as transforming growth factor-beta (TGF-β) from lipid microcylinders. Release of TGF-β from the microcylinders follows first-order kinetics. The rate of release can be modulated by increasing the temperature which results in a thermotrophic phase transition of the lipid at 43 °C.

Copyright

References

Hide All
1. Ostro, M.J., and Cullis, P.R., Am. J. Hosp. Pharm. 46, 1576 (1989).
2. Djordjevich, L., and Miller, I.F., Exp. Hematol. 8, 584 (1980).
3. Gabizon, A., Shiota, R., and Papahadjopoulos, D., J. Natl. Cancer Inst. 81, 1484 (1989).
4. Rudolph, A.S., Stilwell, G.E., Monroy, R.L. and Rollwagen, F., J. Cell. Biochem. 15F, 190 (1991).
5. Yager, P. and Schoen, P.E., Mol. Liq. Cryst. 106, 371 (1984).
6. Georger, J.H., Singh, A., Price, R.L., Schnur, J.M., Yager, P., and Schoen, P.E., J. Am. Chem. Soc. 109, 6169 (1987).
7. Burke, T.G, Rudolph, A.S., Sheridan, J.P., Dielzehl, A.D., Singh, A., and Shoen, P.E., Chem. Phys. Lipids 48, 215 (1988).
8. Ferrante, and Thong, , J. Immun. Meth. 36, 109 (1980)
9. Papahadjopoulos, D. and Gabizon, A., Annal. N.Y. Acad. Sci. 507, 64 (1987).
10. Allen, T.M., Hansen, C., and Rutledge, J., Biochim. Biophys. Acta 981, 27 (1989).

Technological Development of Lipid-Based Microcylinders: Biocompatibility and Controlled Release

  • Barry J. Spargo (a1), Geoffrey E. Stilwell (a2), Richard O. Cliff (a2), Rod L. Monroy (a3), Florence M. Rollwagen (a3) and Alan S. Rudolph (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed